| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 32 |
| 1 | METHOTREXATE | 29 |
| 2 | PREDNISONE | 24 |
| 3 | TACROLIMUS | 23 |
| 4 | LENALIDOMIDE | 22 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 21 |
| 6 | TACROLIMUS OINTMENT 0.1% | 21 |
| 7 | CYCLOSPORINE | 20 |
| 8 | DEXAMETHASONE | 19 |
| 9 | DEXAMETHASONE 1.5 MG | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE | 1 | 0.0303 |
| 1 | NITROGEN | 1 | 0.0090 |
| 2 | PORFIMER SODIUM | 2 | 0.0059 |
| 3 | BEROTRALSTAT HYDROCHLORIDE | 1 | 0.0011 |
| 4 | BELATACEPT | 5 | 0.0011 |
| 5 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 6 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 5 | 0.0008 |
| 7 | TAZEMETOSTAT | 1 | 0.0006 |
| 8 | ALOGLIPTIN | 2 | 0.0006 |
| 9 | MITOTANE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 66 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 2 | Platinum-based Drug [EPC] | 28 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 24 |
| 4 | Thalidomide Analog [EPC] | 22 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 20 |
| 6 | Proton Pump Inhibitor [EPC] | 18 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 17 |
| 8 | Microtubule Inhibitor [EPC] | 15 |
| 9 | Purine Antimetabolite [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 5 | 0.0011 |
| 1 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 20 | 0.0002 |
| 3 | Purine Antimetabolite [EPC] | 14 | 0.0001 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 11 | 0.0001 |
| 6 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 28 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 15 | 0.0001 |